Accessibility Menu
GoodRx logo

GoodRx

(NASDAQ) GDRX

Current Price$3.16
Market Cap$1.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2020)-94%
5 Year-89%
1 Year-34%
1 Month+20%
GoodRx last closing stock price
MetricPriceDate
Last closeUSD 3.142026-07-17
GoodRx stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+6.44%USD 2.952026-07-10
1 month+20.31%USD 2.612026-06-17
3 month+38.33%USD 2.272026-04-17
Year to date+15.87%USD 2.712025-12-31
1 year-33.62%USD 4.732025-07-17
3 year-58.9%USD 7.642023-07-18
5 year-89.4%USD 29.632021-07-16
Since inception-93.78%USD 50.502020-09-23

GoodRx Financials at a Glance

Market Cap

$1.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$787.89M

Net Income (TTM)

$20.56M

EPS (TTM)

$0.06

P/E Ratio

53.68

Dividend

$0.00

Beta (Volatility)

1.75 (High)

Price

$3.16

Volume

163,303

Open

$3.10

Previous Close

$3.16

Daily Range

$3.06 - $3.18

52-Week Range

$1.77 - $5.81

Estimated Earnings Date

Aug 5, 2026

GDRX News

Mother and child on telehealth call with doctor

Best Telemedicine and Telehealth Stocks for 2026 and How to Invest

Keith SpeightsMay 19, 2026
gdrx-hims_quarter_revenue_bar_primary_standard_limit8.png

GoodRx vs. Hims & Hers Health: Stagnation vs. Growth in Revenue

Cory RenauerMay 10, 2026
pharmacy drug store shopping sick-1200x675-128554e

How GoodRx Makes Money

Rachel WarrenOct 18, 2025
Two people participating in a telehealth session

Why GoodRx Holdings Stock Triumphed on Thursday

Eric VolkmanMay 8, 2025
Two people participating in a telehealth session

Why GoodRx Holdings Stock Was Sinking This Week

Eric VolkmanNov 8, 2024
GettyImages-1457776650

Why GoodRx Surged Today

Billy DubersteinMar 25, 2024
Man holding prescription in front of laptop computer

Why GoodRx Stock Soared Today

Steve SymingtonFeb 29, 2024
Stethescope atop US currency and coins

Why GoodRx Holdings Stock Dived by Nearly 19% Today

Eric VolkmanNov 9, 2023
Page 1

GDRX: Motley Fool Moneyball Superscore

49

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About GoodRx

GoodRx helps Americans find lower prices for their prescription drugs. It lets people compare costs at different pharmacies on their phones. This makes healthcare more affordable for people with or without insurance.

Pills, Plans, and Digital Tools

  • Prescription Transactions: Provides free codes to access negotiated drug prices at retail pharmacies nationwide.
  • Subscription Offerings: Offers deeper savings and home delivery through paid monthly plans like Gold and RxSmartSaver+.
  • Pharma Direct: Integrates drug manufacturer discounts and advertisements directly into the platform to lower brand-name medicine costs.
  • Telehealth Services: Connects patients with medical professionals for virtual visits and prescriptions via the GoodRx Care platform.

Growing the Platform

  • Started a collaboration with TrumpRx.gov in February 2026 to provide discounted drug prices on a government-sponsored platform.
  • Launched condition-specific subscriptions in June 2025 to bundle doctor visits and medications for chronic health issues.
  • Introduced the RxSmartSaver+ program in July 2025 through partnerships with specific retail pharmacies.
  • Initiated an integrated savings program in 2023 to apply discounts automatically for certain health plan members.
  • Entered into direct contractual agreements with select pharmacies starting in 2022 to negotiate more competitive prescription prices.

What Drives the Business?

The company uses a proprietary engine to process over 420 billion pricing data points every day for consumers. Its platform integrates directly into Electronic Health Record (EHR) systems, which are digital patient charts used by doctors.

Financial Results by Period

  • Revenue was $194.8 million in Q4 2025, down 1.9% from $198.6 million in Q4 2024.
  • Operating income reached $23.8 million in Q4 2025, up 30.9% from $18.2 million the year before.
  • Gross profit was $111.9 million in Q4 2025, representing a 40% decrease from $186.4 million in Q4 2024.
  • Free cash flow grew to $31.6 million in Q4 2025, up 12.6% year-over-year.
  • Net income was $5.4 million in Q4 2025, down 19.5% from $6.7 million in the prior year.

Bottom Line

GoodRx has evolved from a simple price comparison tool into a broad digital platform for subscriptions and pharmaceutical manufacturer solutions. It continues to position itself as a central connector for affordability across the American healthcare system.

AI Generated • May 3, 2026

Industry

Health Care Technology

Sector

Health Care

Employees

697

CEO

Wendy Barnes, MBA

Website

www.goodrx.com

Headquarters

Santa Monica, CA 90404, US

GDRX Financials

Key Financial Metrics (TTM)

Gross Margin

86.56%

Operating Margin

10.73%

Net Income Margin

2.61%

Return on Equity

3.31%

Return on Capital

7.55%

Return on Assets

1.02%

Earnings Yield

1.86%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

338.68M

Volume

163.30K

Avg. Volume

1.45M

Financials (TTM)

Gross Profit

$681.98M

Operating Income

$84.56M

EBITDA

$173.34M

Operating Cash Flow

$170.33M

Capital Expenditure

-$73.79M

Free Cash Flow

$96.54M

Cash & ST Invst.

$235.71M

Total Debt

$541.35M

GoodRx Performance Analysis

GoodRx annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 766,554,0002.8%
20232023-12-31USD 750,265,000-2.1%
20242024-12-31USD 792,324,0005.6%
20252025-12-31USD 796,853,0000.6%
GoodRx sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-300.0%
Q32025-09-30-3.5%
Q42025-12-31-0.6%
Q12026-03-31-0.4%
GoodRx annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -0.0826.2%
20232023-12-31USD -0.02-72.8%
20242024-12-31USD 0.04N/A
20252025-12-31USD 0.09104.1%
GoodRx sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3020.0%
Q32025-09-30-91.1%
Q42025-12-31396.9%
Q12026-03-31-78.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$194.01M

-4.4%

Gross Profit

$152.06M

-19.8%

Gross Margin

78.38%

N/A

Market Cap

$1.06BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.53M

N/A

Employees

697

N/A

Net Income

$1.17M

-89.4%

EBITDA

$37.20M

-22.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$235.71M

-21.7%

Total Debt

$541.35M

+0.0%

Accounts Receivable

$244.62M

+42.2%

Inventory

$0.00

N/A

Long Term Debt

$531.38M

+0.1%

Short Term Debt

$9.98M

-5.5%

Return on Assets

1.02%

N/A

Return on Invested Capital

7.28%

N/A

Free Cash Flow

-$9.81M

+21.3%

Operating Cash Flow

$11.84M

+25.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
COLLCollegium Pharmaceutical, Inc.
$36.08-0.52%
IRMDIRadimed Corporation
$97.03-0.76%
AMPHAmphastar Pharmaceuticals, Inc.
$19.75-0.58%
HSTMHealthStream, Inc.
$28.48-1.59%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.53-0.02%
AALAmerican Airlines Group
$14.98-0.04%
PATHUiPath
$12.15+0.01%
JOBYJoby Aviation
$7.23-0.01%

Questions About GDRX

What is the current price of GoodRx?

GoodRx is trading at $3.16 per share.

What is the 52-week range for GoodRx?

Over the past 52 weeks, GoodRx has traded between $1.77 and $5.81.

How much debt does GoodRx have?

As of the most recent reporting period, GoodRx reported total debt of $541.35M.

How much cash does GoodRx have on hand?

GoodRx reported $235.71M in cash and cash equivalents in its most recent financial results.

What is GoodRx’s dividend yield?

GoodRx does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services